Top compounds associated with response to PRAMEF4

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	navitoclax:MST-312 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.011	0.8
mRNA	thalidomide	CTRPv2	pan-cancer	AAC	0.016	0.8
mRNA	paclitaxel	UHNBreast	pan-cancer	AAC	-0.097	0.8
mRNA	selumetinib:BRD-A02303741 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.01	0.8
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.009	0.8
mRNA	bafilomycin A1	CTRPv2	pan-cancer	AAC	-0.036	0.8
mRNA	NVP-BEZ235	CTRPv2	pan-cancer	AAC	0.012	0.8
mRNA	DBeQ	CTRPv2	pan-cancer	AAC	0.01	0.8
mRNA	BRD8899	CTRPv2	pan-cancer	AAC	-0.011	0.8
mRNA	cabozantinib	CTRPv2	pan-cancer	AAC	-0.01	0.8

Download CSV